Atypical wounds. Best clinical practice and challenges
2019; Mark Allen Group; Volume: 28; Issue: Sup6 Linguagem: Inglês
10.12968/jowc.2019.28.sup6.s1
ISSN2052-2916
AutoresKirsi Isoherranen, Julie O’Brien, Judith C. Barker, Joachim Dissemond, Jürg Hafner, Gregor B. E. Jemec, Jivko Kamarachev, Severin Läuchli, Elena Conde Montero, Stephan Nobbe, Cord Sunderkötter, Mar Llamas‐Velasco,
Tópico(s)Chemotherapy-related skin toxicity
ResumoJournal of Wound CareVol. 28, No. Sup6 Atypical wounds. Best clinical practice and challengesKirsi Isoherranen, Julie Jordan O'Brien, Judith Barker, Joachim Dissemond, Jürg Hafner, Gregor B. E. Jemec, Jivko Kamarachev, Severin Läuchli, Elena Conde Montero, Stephan Nobbe, Cord Sunderkötter, Mar Llamas VelascoKirsi IsoherranenHelsinki University Central Hospital and Helsinki University, Wound Healing Centre and Dermatology Clinic, Helsinki, FinlandSearch for more papers by this author, Julie Jordan O'BrienAdvanced Nurse Practitioner Plastic Surgery, Beaumont Hospital, Dublin, IrelandSearch for more papers by this author, Judith BarkerNurse Practitioner - Wound Management, Rehabilitation, Aged and Community Care., Adjunct Associate Professor, University of Canberra, Canberra, AustraliaSearch for more papers by this author, Joachim DissemondUniversity Hospital of Essen, Department of Dermatology, Venerology and Allergology, Hufelandstraße 55, Essen, GermanySearch for more papers by this author, Jürg HafnerDepartment of Dermatology, University Hospital of Zurich, Gloriastrasse 31, Zurich, SwitzerlandSearch for more papers by this author, Gregor B. E. JemecDepartment of Dermatology, Zealand University Hospital, Roskilde, DenmarkSearch for more papers by this author, Jivko KamarachevDepartment of Dermatology, University Hospital of Zurich, Gloriastrasse 31, Zurich, SwitzerlandSearch for more papers by this author, Severin LäuchliDepartment of Dermatology, University Hospital of Zurich, Gloriastrasse 31, Zurich, SwitzerlandSearch for more papers by this author, Elena Conde MonteroHospital Universitario Infanta Leonor, Dept. of Dermatology, Madrid, SpainSearch for more papers by this author, Stephan NobbeDepartment of Dermatology, University Hospital of Zurich, Gloriastrasse 31, Zurich, Switzerland Department of Dermatology, Cantonal Hospital of Frauenfeld, SwitzerlandSearch for more papers by this author, Cord SunderkötterChair, Department of Dermatology and Venerology, University and University Hospital of Halle, Ernst-Grube-Strasse 40, Halle, GermanySearch for more papers by this author, Mar Llamas VelascoDepartment of Dermatology, Hospital Universitario De La Princesa, Madrid, SpainSearch for more papers by this authorKirsi Isoherranen; Julie Jordan O'Brien; Judith Barker; Joachim Dissemond; Jürg Hafner; Gregor B. E. Jemec; Jivko Kamarachev; Severin Läuchli; Elena Conde Montero; Stephan Nobbe; Cord Sunderkötter; Mar Llamas VelascoPublished Online:6 Jun 2019https://doi.org/10.12968/jowc.2019.28.Sup6.S1AboutSectionsView articleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareShare onFacebookTwitterLinked InEmail View article17. References1. Health Service Executive. Multidiscip. Team Health Serv. Exec. (2013) Google Scholar2. Wiecha J, Pollard T. The interdisciplinary eHealth team: chronic care for the future. J Med Internet Res 2004; 6(3):e22. https://doi.org/10.2196%2Fjmir.6.3.e22 Crossref, Medline, Google Scholar3. Shanmugam VK, Angra D, Rahimi H, McNish S. Vasculitic and autoimmune wounds. J Vasc Surg Venous Lymphat Disord 2017; 5(2):280–292. https://doi.org/10.1016/j.jvsv.2016.09.006 Crossref, Medline, Google Scholar4. Shanmugam VK, Schilling A, Germinario A et al.. Prevalence of immune disease in patients with wounds presenting to a tertiary wound healing centre. Int Wound J 2012; 9(4):403–411. https://doi.org/10.1111/j.1742-481X.2011.00899.x Crossref, Medline, Google Scholar5. Körber A, Klode J, Al-Benna S et al.. Etiology of chronic leg ulcers in 31,619 patients in Germany analyzed by an expert survey. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2011; 9(2):116–121. https://doi.org/10.1111/j.1610-0387.2010.07535.x Crossref, Medline, Google Scholar6. Shelling ML, Federman DG, Kirsner RS. Clinical approach to atypical wounds with a new model for understanding hypertensive ulcers. Arch Dermatol 2010; 146(9):1026–1029. https://doi.org/10.1001/archdermatol.2010.213 Crossref, Medline, Google Scholar7. Hoffman MD. Atypical ulcers. Dermatol Ther 2013; 26(3):222–235. https://doi.org/10.1111/dth.12048 Crossref, Medline, Google Scholar8. Mooij MC, Huisman LC. Chronic leg ulcer: does a patient always get a correct diagnosis and adequate treatment? Phlebology 2016; 31(1_suppl Suppl):68–73. https://doi.org/10.1177/0268355516632436 Crossref, Medline, Google Scholar9. Alavi A, Sibbald RG, Phillips TJ et al.. What's new: Management of venous leg ulcers. J Am Acad Dermatol 2016; 74(4):627–640. https://doi.org/10.1016/j.jaad.2014.10.048 Crossref, Medline, Google Scholar10. Hradil E, Jeppsson C, Hamnerius N, Svensson Å. The diagnosis you wish you had never operated on: Pyoderma gangrenosum misdiagnosed as necrotizing fasciitis—a case report. Acta Orthop 2017; 88(2):231–233. https://doi.org/10.1080/17453674.2016.12 60403 Crossref, Medline, Google Scholar11. Janowska A, Oranges T, Chiricozzi A et al.. Synergism of Therapies After Postoperative Autograft Failure in a Patient With Melanoma of the Foot Misdiagnosed as a Pressure Ulcer. Wounds 2018; 30(4):E41–E43 Medline, Google Scholar12. Langan SM, Groves RW, Card TR, Gulliford MC. Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 2012; 132(9):2166–2170. https://doi.org/10.1038/jid.2012.130 Crossref, Medline, Google Scholar13. García-Lozano JA, Ocampo-Candiani J, Martínez-Cabriales SA, Garza-Rodríguez V. An Update on Calciphylaxis. Am J Clin Dermatol 2018; 19(4):599–608. https://doi.org/10.1007/s40257-018-0361-x Crossref, Medline, Google Scholar14. Jones B, Lake A, Harper C. My wound and I: patients' perspective. J Vis Commun Med 2016; 39(3-4):120–126. https://doi.org/10.1080/174 53054.2016.1246060 Crossref, Medline, Google Scholar15. Solowiej K, Mason V, Upton D. Review of the relationship between stress and wound healing: part 1. J Wound Care 2009; 18(9):357–366. https://doi.org/10.12968/jowc.2009.18.9.44302 Link, Google Scholar16. Tiri H, Huilaja L, Jokelainen J et al.. Women with Hidradenitis Suppurativa Have an Elevated Risk of Suicide. J Invest Dermatol 2018; 138(12):2672–2674. https://doi.org/10.1016/j.jid.2018.06.171 Crossref, Medline, Google Scholar17. Al Ghazal P, Herberger K, Schaller J et al.. Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients. Orphanet J Rare Dis 2013; 8(1):136. https://doi.org/10.1186/1750-1172-8-136 Crossref, Medline, Google Scholar18. Jockenhöfer F, Klode J, Kröger K et al.. Patients with pyoderma gangrenosum - analyses of the German DRG data from 2012. Int Wound J 2016; 13(5):951–956. https://doi.org/10.1111/iwj.12463 Crossref, Medline, Google Scholar19. Wang EA, Steel A, Luxardi G et al.. Classic Ulcerative Pyoderma Gangrenosum Is a T Cell-Mediated Disease Targeting Follicular Adnexal Structures: A Hypothesis Based on Molecular and Clinicopathologic Studies. Front Immunol 2018; 8:1980. https://doi.org/10.3389/fimmu.2017.01980 Crossref, Medline, Google Scholar20. Marzano AV, Borghi A, Meroni PL, Cugno M. Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 2016; 175(5):882–891. https://doi.org/10.1111/bjd.14691 Crossref, Medline, Google Scholar21. Cugno M, Borghi A, Marzano AV. PAPA, PASH and PAPASH Syndromes: Pathophysiology, Presentation and Treatment. Am J Clin Dermatol 2017; 18(4):555–562. https://doi.org/10.1007/s40257-017-0265-1 Crossref, Medline, Google Scholar22. Cosgarea I, Lovric Z, Körber A, Dissemond J. Successful treatment of refractory pyoderma gangrenosum with ustekinumab only after excision of renal cell carcinoma. Int Wound J 2016; 13(5):1041–1042. https://doi.org/10.1111/iwj.12377 Crossref, Medline, Google Scholar23. Hadi A, Lebwohl M. Clinical features of pyoderma gangrenosum and current diagnostic trends. J Am Acad Dermatol 2011; 64(5):950–954.e2. https://doi.org/10.1016/j.jaad.2010.01.049 Crossref, Medline, Google Scholar24. Herberger K, Dissemond J, Hohaus K et al.. Treatment of pyoderma gangrenosum: retrospective multicentre analysis of 121 patients. Br J Dermatol 2016; 175(5):1070–1072. https://doi.org/10.1111/bjd.14619 Crossref, Medline, Google Scholar25. Barbosa NS, Tolkachjov SN, el-Azhary RA et al.. Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013. J Am Acad Dermatol 2016; 75(5):931–939. https://doi.org/10.1016/j.jaad.2016.05.044 Crossref, Medline, Google Scholar26. Zuo KJ, Fung E, Tredget EE, Lin AN. A systematic review of post-surgical pyoderma gangrenosum: Identification of risk factors and proposed management strategy. J Plast Reconstr Aesthet Surg 2015; 68(3):295–303. https://doi.org/10.1016/j.bjps.2014.12.036 Crossref, Medline, Google Scholar27. Larcher L, Schwaiger K, Eisendle K et al.. Aesthetic breast augmentation mastopexy followed by post-surgical pyoderma gangrenosum (pspg): clinic, treatment, and review of the literature. Aesthetic Plast Surg 2015; 39(4):506–513. https://doi.org/10.1007/s00266-015-0499-3 Crossref, Medline, Google Scholar28. André MF, Piette JC, Kémény JL et al..; French Study Group on Aseptic Abscesses. Aseptic Abscesses. Medicine (Baltimore) 2007; 86(3):145–161. https://doi.org/10.1097/md.0b013e18064f9f3 Crossref, Medline, Google Scholar29. Jockenhöfer F, Wollina U, Salva KA et al.. The PARACELSUS score: a novel diagnostic tool for pyoderma gangrenosum. Br J Dermatol 2018; https://doi.org/10.1111/bjd.16401 Medline, Google Scholar30. Maverakis E, Ma C, Shinkai K et al.. Diagnostic Criteria of Ulcerative Pyoderma Gangrenosum. JAMA Dermatol 2018; 154(4):461–466. https://doi.org/10.1001/jamadermatol.2017.5980 Crossref, Medline, Google Scholar31. Kutlubay Z, Tüzün Y, Wolf R. The pathergy test as a diagnostic tool. Skinmed 2017; 15(2):97–104 Medline, Google Scholar32. Al Ghazal P, Dissemond J. Therapy of pyoderma gangrenosum in Germany: results of a survey among wound experts. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 2015; 13(4):317–324. https://doi.org/10.1111/ddg.12585 Crossref, Medline, Google Scholar33. Partridge AC, Bai JW, Rosen CF et al. Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials. Br J Dermatol 2018; 179(2):290–295. https://doi.org/10.1111/bjd.16485 Medline, Google Scholar34. Ormerod AD, Thomas KS, Craig FE et al.. Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ 2015; 350 jun12 3:h2958. https://doi.org/10.1136/bmj.h2958 Crossref, Medline, Google Scholar35. Brooklyn TN, Dunnill MG, Shetty A et al.. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006; 55(4):505–509. https://doi.org/10.1136/gut.2005.074815 Crossref, Medline, Google Scholar36. Dissemond J, Assenheimer B, Engels P et al.. M.O.I.S.T. - a concept for the topical treatment of chronic wounds. JDDG 2017; 15(4):443–445. https://doi.org/10.1111/ddg.13215 Google Scholar37. Leiphart PA, Lam CC, Foulke GT. Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement. JAAD Case Rep 2018; 4(1):98–100. https://doi.org/10.1016/j.jdcr.2017.08.009 Crossref, Medline, Google Scholar38. Strohal R, Dissemond J, Jordan O'Brien J et al.. EWMA Document: Debridement: An updated overview and clarification of the principle role of debridement. J Wound Care 2013; 22(Sup1 Suppl):S1–S49. https://doi.org/10.12968/jowc.2013.22.Sup1.S1 Link, Google Scholar39. Seo HI, Lee HJ, Han KH. Hyperbaric oxygen therapy for pyoderma gangrenosum associated with ulcerative colitis. Intest Res 2018; 16(1):155–157. https://doi.org/10.5217/ir.2018.16.1.155 Crossref, Medline, Google Scholar40. Pichler M, Thuile T, Gatscher B et al.. Systematic review of surgical treatment of pyoderma gangrenosum with negative pressure wound therapy or skin grafting. J Eur Acad Dermatol Venereol 2017; 31(2):e61–e67. https://doi.org/10.1111/jdv.13727 Crossref, Medline, Google Scholar41. Dissemond J, Storck M, Kröger K, Stücker M. [Indications and contraindications for modern compression therapy]. [Article in German]. Wien Med Wochenschr 2018; 168(9-10):228–235. https://doi.org/10.1007/s10354-017-0605-z Crossref, Medline, Google Scholar42. Wilkes SR, Williams HC, Ormerod AD et al.. Is speed of healing a good predictor of eventual healing of pyoderma gangrenosum? J Am Acad Dermatol 2016; 75(6):1216–1220.e2. https://doi.org/10.1016/j.jaad.2016.07.049 Crossref, Medline, Google Scholar43. Jennette JC, Falk RJ, Bacon PA et al.. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65(1):1–11. https://doi.org/10.1002/art.37715 Crossref, Medline, Google Scholar44. Linos K, Cribier B, Carlson J. Cutaneous cryoglobulinemic vasculitis. In: Dammacco F: HCV infection and cryoglobulinemia. Springer Verl, 2012 Crossref, Google Scholar45. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet 2012; 379(9813):348–360. https://doi.org/10.1016/S0140-6736(11)60242-0 Crossref, Medline, Google Scholar46. Terrier B, Karras A, Kahn JE et al.. The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases. Medicine (Baltimore) 2013; 92(2):61–68. https://doi.org/10.1097/MD.0b013e318288925c Crossref, Medline, Google Scholar47. Sunderkötter CH et al.. Nomenclature of Cutaneous Vasculitis: Dermatologic Addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheumatol. Hoboken NJ 70, 171–184 (2018) Google Scholar48. Yus ES, Simón RS, Requena L. Vein, artery, or arteriole? A decisive question in hypodermal pathology. Am J Dermatopathol 2012; 34(2):229–232. https://doi.org/10.1097/DAD.0b013e3182157ed1 Crossref, Medline, Google Scholar49. Criado PR, Marques GF, Morita TC, de Carvalho JF. Epidemiological, clinical and laboratory profiles of cutaneous polyarteritis nodosa patients: Report of 22 cases and literature review. Autoimmun Rev 2016; 15(6):558–563. https://doi.org/10.1016/j.autrev.2016.02.010 Crossref, Medline, Google Scholar50. Carlson JA, Chen KR. Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes. Am J Dermatopathol 2007; 29(1):32–43. https://doi.org/10.1097/01.dad.0000245198.80847.ff Crossref, Medline, Google Scholar51. Sunderkötter C, de Groot K. [Therapy of vasculitis and vasculopathies]. [Article in German]. Hautarzt 2008; 59(5):382–393. https://doi.org/10.1007/s00105-008-1530-2 Medline, Google Scholar52. Yang YH, Yu HH, Chiang BL. The diagnosis and classification of Henoch–Schönlein purpura: An updated review. Autoimmun Rev 2014; 13(4-5):355–358. https://doi.org/10.1016/j.autrev.2014.01.031 Crossref, Medline, Google Scholar53. Heineke MH, Ballering AV, Jamin A et al.. New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura). Autoimmun Rev 2017; 16(12):1246–1253. https://doi.org/10.1016/j.autrev.2017.10.009 Crossref, Medline, Google Scholar54. Sunderkötter C. Vasculitis of small blood vessels - some riddles about IgA and about the complexity of transmigration. Exp Dermatol 2009; 18(1):91–96. https://doi.org/10.1111/j.1600-0625.2008.00791.x Crossref, Medline, Google Scholar55. Sunderkötter C, Seeliger S, Schönlau F et al.. Different pathways leading to cutaneous leukocytoclastic vasculitis in mice. Exp Dermatol 2001 Dec;10(6):391–404. https://doi.org/10.1034/j.1600-0625.2001.100602.x Crossref, Medline, Google Scholar56. Sindrilaru A, Seeliger S, Ehrchen JM et al.. Site of blood vessel damage and relevance of CD18 in a murine model of immune complex-mediated vasculitis. J Invest Dermatol 2007; 127(2):447–454. https://doi.org/10.1038/sj.jid.5700563 Crossref, Medline, Google Scholar57. Requena L, Kutzner H, Angulo J, Renedo G. Generalized livedo reticularis associated with monoclonal cryoglobulinemia and multiple myeloma. J Cutan Pathol 2007; 34(2):198–202. https://doi.org/10.1111/j.1600-0560.2006.00594.x Crossref, Medline, Google Scholar58. Braverman IM, Yen A. Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angitis. J Invest Dermatol 1975; 64(2):105–112. https://doi.org/10.1111/1523-1747.ep12510321 Crossref, Medline, Google Scholar59. Gower RG, Mitchell Sams W Jr et al.. Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol 1977; 69(5):477–484. https://doi.org/10.1111/1523-1747.ep12511631 Crossref, Medline, Google Scholar60. Arora A, Wetter DA, Gonzalez-Santiago TM et al.. Incidence of leukocytoclastic vasculitis, 1996 to 2010: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 2014; 89(11):1515–1524. https://doi.org/10.1016/j.mayocp.2014.04.015 Crossref, Medline, Google Scholar61. García-Porrúa C, González-Gay MA. Comparative clinical and epidemiological study of hypersensitivity vasculitis versus Henoch-Schönlein purpura in adults. Semin Arthritis Rheum 1999; 28(6):404–412. https://doi.org/10.1016/S0049-0172(99)80006-7 Crossref, Medline, Google Scholar62. Sunderkötter C, Bonsmann G, Sindrilaru A, Luger T. Management of leukocytoclastic vasculitis. J Dermatolog Treat 2005; 16(4):193–206. https://doi.org/10.1080/09546630500277971 Crossref, Medline, Google Scholar63. Schroeter AL, Conn DL, Jordon RE. Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis 1976; 35(4):321–326. https://doi.org/10.1136/ard.35.4.321 Crossref, Medline, Google Scholar64. Chen KR, Toyohara A, Suzuki A, Miyakawa S. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis. Br J Dermatol 2002; 147(5):905–913. https://doi.org/10.1046/j.1365-2133.2002.04933.x Crossref, Medline, Google Scholar65. Ramos-Casals M, Nardi N, Lagrutta M et al.. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients. Medicine (Baltimore) 2006; 85(2):95–104. https://doi.org/10.1097/01.md.0000216817.35937.70 Crossref, Medline, Google Scholar66. Yates M, Watts R. ANCA-associated vasculitis. Clin Med (Northfield Ill) 2017; 17(1):60–64. https://doi.org/10.7861/clinmedicine.17-1-60 Crossref, Medline, Google Scholar67. K, Krumbholz M, Schönermarck U, Back W et al.. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med 2009; 15(6):623–625. https://doi.org/10.1038/nm.1959 Crossref, Medline, Google Scholar68. Chen KR. Skin involvement in ANCA-associated vasculitis. Clin Exp Nephrol 2013; 17(5):676–682. https://doi.org/10.1007/s10157-012-0736-x Crossref, Medline, Google Scholar69. Geetha D, Jin Q, Scott J, Hruskova Z et al.. Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Kidney Int Rep 2018; 3(5):1039–1049. https://doi.org/10.1016/j.ekir.2018.05.007 Crossref, Medline, Google Scholar70. Schirmer JH, Aries PM, de Groot K et al.. S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis. Z Rheumatol 2017; 76(S3 Suppl 3):77–104. https://doi.org/10.1007/s00393-017-0394-1 Crossref, Medline, Google Scholar71. Segura S, Pujol RM, Trindade F, Requena L. Vasculitis in erythema induratum of Bazin: A histopathologic study of 101 biopsy specimens from 86 patients. J Am Acad Dermatol 2008; 59(5):839–851. https://doi.org/10.1016/j.jaad.2008.07.030 Crossref, Medline, Google Scholar72. Llamas-Velasco M, Alegría V, Santos-Briz Á et al.. Occlusive Nonvasculitic Vasculopathy. Am J Dermatopathol 2017; 39(9):637–662. https://doi.org/10.1097/DAD.0000000000000766 Crossref, Medline, Google Scholar73. Carlson JA, Chen KR. Cutaneous Pseudovasculitis. Am J Dermatopathol 200729(1):44–55. https://doi.org/10.1097/01.dad.0000245195.35106.3c Crossref, Google Scholar74. Ehrmann S. [A new vascular symptom of syphilis.] Wien Med Wochenschr 1907; 57:777–782 Google Scholar75. Lie JT. Cholesterol atheromatous embolism. The great masquerader revisited. Pathol Annu 1992; 27(Pt 2):17–50 Medline, Google Scholar76. Ghanem F, Vodnala D, K Kalavakunta J et al.. Cholesterol crystal embolization following plaque rupture: a systemic disease with unusual features. J Biomed Res 2017; 31(2):82–94 Medline, Google Scholar77. Marneros AG, Blanco F, Husain S et al. Classification of cutaneous intravascular breast cancer metastases based on immunolabeling for blood and lymph vessels. J Am Acad Dermatol 2009; 60(4):633–638. https://doi.org/10.1016/j.jaad.2008.11.008 Crossref, Medline, Google Scholar78. Lugassy C, Zadran S, Bentolila LA et al.. Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination. Cancer Microenviron 2014; 7(3):139–152. https://doi.org/10.1007/s12307-014-0156-4 Crossref, Medline, Google Scholar79. Alcaraz I, Cerroni L, Rütten A et al.. Cutaneous metastases from internal malignancies: a clinicopathologic and immunohistochemical review. Am J Dermatopathol 2012; 34(4):347–393. https://doi.org/10.1097/DAD.0b013e31823069cf Crossref, Medline, Google Scholar80. Vinson RP, Chung A, Elston DM, Keller RA. Septic microemboli in a Janeway lesion of bacterial endocarditis. J Am Acad Dermatol 1996; 35(6):984–985. https://doi.org/10.1016/S0190-9622(96)90125-5 Crossref, Medline, Google Scholar81. Alpert JS. Osler's nodes and Janeway lesions are not the result of small-vessel vasculitis. Am J Med 2013; 126(10):843–844. https://doi.org/10.1016/j.amjmed.2013.04.002 Crossref, Medline, Google Scholar82 Delgado-Jiménez Y, Fraga J, Fernández-Herrera J, García-Diez A. [Septic vasculopathy] Actas Dermo-Sifiliograficas 2007; 98(Suppl 1):22–28 Medline, Google Scholar83. Habib G, Lancellotti P, Antunes MJ et al.. 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J 2015; 36(44):3075–3128. https://doi.org/10.1093/eurheartj/ehv319 Crossref, Medline, Google Scholar84. Prechel M, Walenga J. Heparin-induced thrombocytopenia: an update. Semin Thromb Hemost 2012; 38(05):483–496. https://doi.org/10.1055/s-0032-1306432 Crossref, Medline, Google Scholar85. Cacoub P, Comarmond C, Domont F et al.. Cryoglobulinemia Vasculitis. Am J Med 2015; 128(9):950–955. https://doi.org/10.1016/j. amjmed.2015.02.017 Crossref, Medline, Google Scholar86. Ramirez GA, Campochiaro C, Salmaggi C et al.. Bortezomib in type I cryoglobulinemic vasculitis: are we acting too late? Intern Med 2015; 54(9):1119–1123. https://doi.org/10.2169/internalmedicine.54.3668 Crossref, Medline, Google Scholar87. Gupta V, El Ters M, Kashani K et al.. Crystalglobulin-Induced Nephropathy. J Am Soc Nephrol 2015; 26(3):525–529. https://doi.org/10.1681/ASN.2014050509 Crossref, Medline, Google Scholar88. Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin-induced skin necrosis. J Am Acad Dermatol 2009; 61(2):325–332. https://doi.org/10.1016/j.jaad.2008.12.039 Crossref, Medline, Google Scholar89. Fred HL. Skin Necrosis Induced by Coumarin Congeners. Tex Heart Inst J 2017; 44(4):233–236. https://doi.org/10.14503/THIJ-17-6430 Crossref, Medline, Google Scholar90. Thornsberry LA, LoSicco KI, English JC 3rd. The skin and hypercoagulable states. J Am Acad Dermatol 2013; 69(3):450–462. https://doi.org/10.1016/j.jaad.2013.01.043 Crossref, Medline, Google Scholar91. Watt SG, Winhoven S, Hay CR, Lucas GS. Purpura fulminans in paroxysmal nocturnal haemoglobinuria. Br J Haematol 2007; 137(4):271. https://doi.org/10.1111/j.1365-2141.2007.06522.x Crossref, Medline, Google Scholar92. Chalmers E, Cooper P, Forman K et al.. Purpura fulminans: recognition, diagnosis and management. Arch Dis Child 2011; 96(11):1066–1071. https://doi.org/10.1136/adc.2010.199919 Crossref, Medline, Google Scholar93. Milstone LM, Braverman IM. PURPLE (oops! Atrophie blanche) revisited. Arch Dermatol 1998; 134(12):1634–1634. https://doi.org/10.1001/archderm.134.12.1634 Crossref, Medline, Google Scholar94. Llamas-Velasco Mde Argila DFraga JGarcía-Diez A. Cutaneous polyarteritis nodosa with manifestations of livedoid vasculopathy. Actas Dermo-Sifiliográficas Engl. Ed. 102, 477–479 (2011). Crossref, Medline, Google Scholar95. Mimouni D, Ng PP, Rencic A et al.. Cutaneous polyarteritis nodosa in patients presenting with atrophie blanche. Br J Dermatol 2003; 148(4):789–794. https://doi.org/10.1046/j.1365-2133.2003.05176.x Crossref, Medline, Google Scholar96. Alavi A, Hafner J, Dutz JP et al.. Livedoid vasculopathy: An in-depth analysis using a modified Delphi approach. J Am Acad Dermatol 2013; 69(6):1033–1042.e1. https://doi.org/10.1016/j.jaad.2013.07.019 Crossref, Medline, Google Scholar97. Vasudevan B, Neema S, Verma R. Livedoid vasculopathy: A review of pathogenesis and principles of management. Indian J Dermatol Venereol Leprol 2016; 82(5):478–488. https://doi.org/10.4103/0378-6323.183635 Crossref, Medline, Google Scholar98. Franco Marques G, Criado PR, Alves Batista Morita TC, Cajas García MS. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban. Int J Dermatol 2018; 57(6):732–741. https://doi.org/10.1111/ijd.13997 Crossref, Medline, Google Scholar99. Micieli R, Alavi A. Treatment for Livedoid Vasculopathy. JAMA Dermatol 2018; 154(2):193–202. https://doi.org/10.1001/jamadermatol.2017.4374 Crossref, Medline, Google Scholar100. Hafner J. Calciphylaxis and Martorell hypertensive ischemic leg ulcer: same pattern - one pathophysiology. Dermatology 2016; 232(5):523–533. https://doi.org/10.1159/000448245 Crossref, Medline, Google Scholar101. Bertranou EG, Gonoraky SE, Otero AE. [Martorell hypertensive arteriolar ulcer: Outpatient outcome on 366 cases]. [Articles in French] Phlebologie 2001; 54:267–272 Google Scholar102. Hafner J, Keusch G, Wahl C, Burg G. Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa 1998; 27(3):137–143 Medline, Google Scholar103. Hafner J, Nobbe S, Partsch H et al.. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol 2010; 146(9):961–968. https://doi.org/10.1001/archdermatol.2010.224 Crossref, Medline, Google Scholar104. Nigwekar SU, Thadhani R, Brandenburg VM. Calciphylaxis. N Engl J Med 2018; 378(18):1704–1714. https://doi.org/10.1056/NEJMra1505292 Crossref, Medline, Google Scholar105. Schnier BR, Sheps SG, Juergens JL. Hypertensive ischemic ulcer. Am J Cardiol 1966; 17(4):560–565. https://doi.org/10.1016/0002-9149(66)90247-5 Crossref, Medline, Google Scholar106. Senet P, Beneton N, Debure C et al.. [Hypertensive leg ulcers: epidemiological characteristics and prognostic factors for healing in a prospective cohort]. [Article in French] Ann Dermatol Venereol 2012; 139(5):346–349. https://doi.org/10.1016/j.annder.2011.09.191 Crossref, Medline, Google Scholar107. Strazzula L, Nigwekar SU, Steele D et al.. Intralesional sodium thiosulfate for the treatment of calciphylaxis. JAMA Dermatol 2013; 149(8):946–949. https://doi.org/10.1001/jamadermatol.2013.4565 Crossref, Medline, Google Scholar108. Kalajian AH, Malhotra PS, Callen JP, Parker LP. Calciphylaxis with normal renal and parathyroid function: not as rare as previously believed. Arch Dermatol 2009; 145(4):451–458. https://doi.org/10.1001/archdermatol.2008.602 Crossref, Medline, Google Scholar109. Nigwekar SU, Wolf M, Sterns RH, Hix JK. Calciphylaxis from nonuremic causes: a systematic review. Clin J Am Soc Nephrol 2008; 3(4):1139–1143. https://doi.org/10.2215/CJN.00530108 Crossref, Medline, Google Scholar110. Ramsey-Stewart G. Eutrophication: spontaneous progressive dermatoliponecrosis. a fatal complication of gross morbid obesity. Obes Surg 1992; 2(3):263–264. https://doi.org/10.1381/096089292765560141 Crossref, Medline, Google Scholar111. Martorell F. [Supra-malleolar ulcers secondary to arteriolitis among women with uncontrolled hypertension]. Actas Reun Cientif Cuerpo Facul Inst Policlin Barc 1945;1(1):6–9 Google Scholar112. Vuerstaek JD, Reeder SW, Henquet CJ, Neumann HA. Arteriolosclerotic ulcer of Martorell. J Eur Acad Dermatol Venereol 2010; 24(8):867–874. https://doi.org/10.1111/j.1468-3083.2009.03553.x Crossref, Medline, Google Scholar113. Santos PW, He J, Tuffaha A, Wetmore JB. Clinical characteristics and risk factors associated with mortality in calcific uremic arteriolopathy. Int Urol Nephrol 2017; 49(12):2247–2256. https://doi.org/10.1007/s11255-017-1721-9 Crossref, Medline, Google Scholar114. Lazareth I, Priollet P. [Necrotic angiodermatitis: treatment by early cutaneous grafts]. [Article in French] Ann Dermatol Venereol 1995; 122(9):575–578 Medline, Google Scholar115. Nicol P, Bernard P, Nguyen P, et al. [Retrospective study of hypertensive leg ulcers at Reims University Hospital: Epidemiological, clinical, disease progression data, effects of vitamin K antagonists]. [Article in French] Ann Dermatol Venereol 2017; 144(1):37–44. https://doi.org/10.1016/j.annder.2016.09.039 Crossref, Medline, Google Scholar116. Priollet P, Juillet Y, Grill S, Phat VN, Housset E. [Necrotic angiodermatitis]. [Article in French] Ann Dermatol Venereol 1984; 111(1):55–61 Medline, Google Scholar117. Senet P, Vicaut E, Beneton N et al. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial. Arch Dermatol 2011; 147(8):926–930. https://doi.org/10.1001/archdermatol.2011.84 Crossref, Medline, Google Scholar118. Brandenburg VM Kramann R, Rothe H et al.. Calcific uraemic arteriolopathy (calciphylaxis): data from a large nationwide registry. Nephrol. Dial. Transplant. Off. Publ. Eur. Dial. Transpl. Assoc. -. Eur Ren Assoc 2017; 32:126–132. https://doi.org/10.1093/ndt/gfv438 Google
Referência(s)